搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Shigella flexneri serotype 5b Spermidine export protein MdtJ (mdtJ), partial CSB-YP608316SGG1
CSB-EP608316SGG1
CSB-BP608316SGG1
CSB-MP608316SGG1
CSB-EP608316SGG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Autoinducer 2 import system permease protein lsrC (lsrC), partial CSB-YP608317SGG
CSB-EP608317SGG
CSB-BP608317SGG
CSB-MP608317SGG
CSB-EP608317SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP608318SGG
CSB-EP608318SGG
CSB-BP608318SGG
CSB-MP608318SGG
CSB-EP608318SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b NH (3)-dependent NAD (+) synthetase (nadE) CSB-YP608319SGG
CSB-EP608319SGG
CSB-BP608319SGG
CSB-MP608319SGG
CSB-EP608319SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Arginine N-succinyltransferase (astA) CSB-YP608320SGG
CSB-EP608320SGG
CSB-BP608320SGG
CSB-MP608320SGG
CSB-EP608320SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Uncharacterized Nudix hydrolase NudL (nudL) CSB-YP608321SGG
CSB-EP608321SGG
CSB-BP608321SGG
CSB-MP608321SGG
CSB-EP608321SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b UPF0283 membrane protein YcjF (ycjF), partial CSB-YP608322SGG1
CSB-EP608322SGG1
CSB-BP608322SGG1
CSB-MP608322SGG1
CSB-EP608322SGG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b UPF0259 membrane protein yciC (yciC), partial CSB-YP608323SGG1
CSB-EP608323SGG1
CSB-BP608323SGG1
CSB-MP608323SGG1
CSB-EP608323SGG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Glutamyl-tRNA reductase (hemA) CSB-YP608324SGG
CSB-EP608324SGG
CSB-BP608324SGG
CSB-MP608324SGG
CSB-EP608324SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Na (+)/H (+) antiporter nhaB (nhaB), partial CSB-YP608325SGG
CSB-EP608325SGG
CSB-BP608325SGG
CSB-MP608325SGG
CSB-EP608325SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Cell division topological specificity factor (minE) CSB-YP608326SGG
CSB-EP608326SGG
CSB-BP608326SGG
CSB-MP608326SGG
CSB-EP608326SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Phosphatase nudJ (nudJ) CSB-YP608327SGG
CSB-EP608327SGG
CSB-BP608327SGG
CSB-MP608327SGG
CSB-EP608327SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Deferrochelatase/peroxidase EfeB (efeB) CSB-YP608328SGG
CSB-EP608328SGG
CSB-BP608328SGG
CSB-MP608328SGG
CSB-EP608328SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Putative aminoacrylate hydrolase RutD (rutD) CSB-YP608329SGG
CSB-EP608329SGG
CSB-BP608329SGG
CSB-MP608329SGG
CSB-EP608329SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b UPF0319 protein YccT (yccT) CSB-YP608330SGG
CSB-EP608330SGG
CSB-BP608330SGG
CSB-MP608330SGG
CSB-EP608330SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Glutathione transport system permease protein gsiC (gsiC), partial CSB-YP608331SGG1
CSB-EP608331SGG1
CSB-BP608331SGG1
CSB-MP608331SGG1
CSB-EP608331SGG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Lipid A palmitoyltransferase PagP (pagP) CSB-YP608332SGG
CSB-EP608332SGG
CSB-BP608332SGG
CSB-MP608332SGG
CSB-EP608332SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b LPS-assembly lipoprotein lptE (lptE) CSB-YP608333SGG
CSB-EP608333SGG
CSB-BP608333SGG
CSB-MP608333SGG
CSB-EP608333SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Glutamine--tRNA ligase (glnS), partial CSB-YP608334SGG
CSB-EP608334SGG
CSB-BP608334SGG
CSB-MP608334SGG
CSB-EP608334SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella flexneri serotype 5b Quinolinate synthase A (nadA) CSB-YP608335SGG
CSB-EP608335SGG
CSB-BP608335SGG
CSB-MP608335SGG
CSB-EP608335SGG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>